đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
The primary objective of this study is to determine the clinical performanc...
Status
Unknown
Location
UniversitĂ€tsklinikum Aachen, Klinik fĂŒr HĂ€matologie, Onkologie, HĂ€mostaseologie
Start Date
2021-08-02
Trial ID
NCT05075122
Treatments Being Tested
UV1 is a therapeutic cancer vaccine that has been explored in prostate and ...
Status
Completed
Location
John Wayne Cancer Center
Start Date
2018-07-09
Trial ID
NCT03538314
This is a randomized, open label study to investigate efficacy and safety o...
Status
Completed
Location
Mayo Clinic Hospital
Start Date
2020-05-27
Trial ID
NCT04382664
Treatments Being Tested
This study, with 20 patients participating, will examine the safety and tol...
Status
Completed
Location
Oslo University Hospital, Radiumhospitalet
Start Date
2015-02-02
Trial ID
NCT02275416
Treatments Being Tested
In this study, up to 21 patients with lung cancer will receive UV1 (a thera...
Status
Completed
Location
Oslo University Hospital
Start Date
2013-04-08
Trial ID
NCT01789099
Treatments Being Tested
The objective of the study is to induce a meaningful progression-free survi...
Status
Active Not Recruiting
Location
University of Western Australia
Start Date
2020-05-04
Trial ID
NCT04300244
Treatments Being Tested
A Randomized, Multicenter Study Investigating Efficacy and Safety of anti-P...
Status
Recruiting
Location
Vestre Viken Health Trust
Start Date
2022-08-12
Trial ID
NCT05344209
Treatments Being Tested
In this study, up to 21 patients with metastatic prostate cancer will recei...
Status
Completed
Location
Oslo University Hospital
Start Date
2013-04-15
Trial ID
NCT01784913
Treatments Being Tested
This prospective, multicenter, open-label, randomized phase II maintenance ...
Status
Active Not Recruiting
Location
Rigshospitalet
Start Date
2021-12-15
Trial ID
NCT04742075
Treatments Being Tested